Dr. Ryan is an LP at Breakout Ventures and Lionheart Ventures. She focuses on women-led ventures as Managing Director of Golden Seeds, and partner in Astia Angels. She has a large portfolio of early-stage companies in San Francisco and Boston. She sits on 5 boards. She was a serial CEO including 2 private and 3 NASDAQ companies.  In her biopharma career she was responsible for bringing antiviral vaccines to global distribution. In her academic career she developed methods for endothelial cell culture and for localization of angiotensin converting enzyme (ACE) in the lungs, a central finding in bringing ACE inhibitors into worldwide use. In the COVID era, understanding the distribution of ACE has enhanced effective vaccine development.  Continuing a career translating science to successful businesses, Dr. Ryan is now translating science to art and founded ULUX www.uluxart.com bringing science perspectives to the art world. Dr. Ryan holds a Ph.D. from Cambridge University, B.Sc. degrees and honorary D.Sc. from Bristol University. Her academic career included Professorships of Medicine at Miami, Washington and Boston Universities. She was Howard Hughes Investigator, American Heart Association Established Investigator, and NIH MERIT Awardee. Her numerous awards include the Albert Einstein Award  for outstanding achievement in the life sciences, the Cartier Award  and World Economic Forum Tech Pioneer. In 2002 Her Majesty Queen Elizabeth II awarded Dr. Ryan the Order of the British Empire (OBE).